MEI Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. MEI Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34% to $65,297,000. The net income raised on $17,778,000 and profit margin reached 27%. Total operating expenses were $50,755,000.
Profit Margin
| 2015 | 0 | -32.69M | |
|---|---|---|---|
| 2016 | 0 | -20.86M | |
| 2017 | 23.24M | 2.67M | 11.48% |
| 2018 | 1.62M | -40.06M | -2470.28% |
| 2019 | 4.91M | -16.81M | -342.2% |
| 2020 | 28.91M | -47.17M | -163.14% |
| 2021 | 25.53M | -50.57M | -198.06% |
| 2022 | 40.69M | -54.73M | -134.5% |
| 2023 | 48.81M | -31.84M | -65.22% |
| 2024 | 65.29M | 17.77M | 27.23% |
0JW9.L Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 65.29M | 48.81M | 40.69M | 25.53M | 28.91M | 4.91M | 1.62M | 23.24M | 0 | 0 |
Cost of revenue | 383K | 1.81M | 1.23M | 1.40M | 2.67M | 4.26M | 3.38M | 5M | 0 | 0 |
Gross profit | 64.91M | 47.00M | 39.46M | 24.12M | 26.24M | 652K | -1.76M | 18.24M | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 16.56M | 52.45M | 85.64M | 69.39M | 34.06M | 32.3M | 17.03M | 7.23M | 13.40M | 23.82M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 50.75M | 85.58M | 116.18M | 93.81M | 50.78M | 46.89M | 26.82M | 15.86M | 21.00M | 32.77M |
Operating income | 14.54M | -36.76M | -75.48M | -69.68M | -24.54M | -46.24M | -28.58M | 2.38M | -21.00M | -32.77M |
Other income (expenses), net | 3.23M | 4.92M | 21.03M | 19.11M | -21.47M | 29.42M | -9.70M | 287K | 143K | 78.00K |
Income before tax | 17.77M | -31.83M | -54.45M | -50.56M | -46.01M | -16.81M | -40.06M | 2.67M | -20.86M | -32.69M |
Income tax expense | 0 | -4.94M | 284K | 8K | 1K | 1K | 1K | 1K | 1K | 1K |
Net income | 17.77M | -31.84M | -54.73M | -50.57M | -47.17M | -16.81M | -40.06M | 2.67M | -20.86M | -32.69M |
Earnings per share | ||||||||||
Basic EPS | 2.67 | -4.78 | -8.8 | -8.99 | -10.4 | -4.73 | -19.34 | 1.4 | -12.2 | -23.2 |
Diluted EPS | 2.67 | -4.78 | -8.75 | -8.84 | -10.4 | -4.65 | -19.34 | 1.45 | -12.13 | -23.18 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |